For research use only. We do not sell to patients.
ML230
CAS No. : 1776055-05-0
Biological Activity：ML230 (CID44640177; SID 88095709) is a selective inhibitor of ATP-binding cassette (ABC) transporter ABCG2, and 36-fold selective for ABCG2 over ABCB1 with EC50s values of 0.13 μM and 4.65 μM, respectively.
Research Area：Cancer
Targets：BCRP
Related Screening Libraries:Bioactive Compound Library Plus;Membrane Transporter/Ion Channel Compound Library;Anti-Cancer Compound Library;Lipid Metabolism Compound Library ;Cancer Stem Cells Compound Library;
Related Small Molecules:PCI 29732;Triclabendazole sulfoxide;Elacridar;P-gp/BCRP-IN-1;YHO-13351;CP-100356 hydrochloride;PD166326;Fumitremorgin C;UR-MB108;Zamicastat;Ko 143;KS176;ML753286;Triclabendazole sulfoxide-d3;Ac32Az19;6,8-Diprenylnaringenin;FD 12-9;Triclabendazole sulfoxide-13C,d3;YHO-13177
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
